Tanda BioTech Contact us

Remove the bottlenecks in bioprocessing.

Starting with filtration.

Precision filtration platforms for low-volume R&D and personalized medicine, through to industrial biomanufacturing.

Small Scale

TxFlow™ Go

The go-to system for day-to-day lab-scale filtration — automated, reproducible, and ready in minutes, down to sub-mL volumes.

0.5 mL – 2 LProcessing range
Large Scale

Perfusion Intensification

Cost-effective reusable perfusion filtration unlocks dramatically higher cell densities — boosting bioreactor output 5–10× through process intensification.

5–10×Bioreactor output
Large Scale

Streamlined Downstream

A re-engineered flow-channel and modular design that cuts cleaning time and cost by 70% and triples effective processing capacity — reusable, with far less waste.

3× capacity70% lower cleaning cost
Small Scale

ReadyPath™ Flow Path

Pre-configured, purpose-built flow path consumables for the TxFlow™ Go — no assembly, minimal hold-up volume, and validated run-to-run reproducibility.

Ready to runPre-configured flow path

Biomanufacturing underpins both human health and a liveable planet.

It is how the newest medicines are made, and it is one of the few credible routes to producing food, materials and chemicals with a fraction of today’s carbon. New therapeutics are emerging faster than at any point in history.

Reaching people is the harder problem. The advanced therapies that work reach only a small share of the patients who qualify for them, and the industries biomanufacturing could decarbonise are among the largest emitters we have.

< 5% of the world’s population can realistically access advanced therapies today. They work — but the manufacturing technology has to change before they can be made affordably and at scale. Estimate · WEF on global access
~25% + 5.8% of global greenhouse-gas emissions come from the food system and from chemicals and petrochemicals — the two sectors biomanufacturing is best placed to change. Our World in Data

Bioprocess requirements are expanding toward both extremes.

Small scale

Advanced therapy and R&D

Production happens at millilitres, in a closed path, across many small batches.

  • Smaller processing volumes
  • Faster turnaround
  • Simpler operation
  • High-throughput parallel runs
  • Scalability
Large scale

Industrial biomanufacturing

Continuous output at capacities batch infrastructure cannot reach economically — or at all, without process intensification.

  • Higher output per unit
  • Longer continuous runs
  • Lower capital and operating cost
  • More consistent batch performance
  • Less manual intervention

The science has moved. Manufacturing has not — filtration least of all.

Existing filtration solutions are not built to fit the scale, so they adapt poorly at either end. Filtration largely decides whether production can scale, whether it can be automated, and whether a streamlined workflow is possible — which makes it one of the highest-priority bottlenecks to remove.

Low volume

R&D · per-patient
01

Not small enough

Can’t handle research-scale volumes — forcing wasteful scale-up or lost sample.

02

Not simple enough

Hours of setup and manual monitoring, with results that vary between operators.

03

Not high throughput

One run at a time caps how many conditions a team can screen.

Large volume

Pilot · production
04

Limited scalability

Throughput bottlenecks appear exactly when processes move to production.

05

Discontinuous batch process

Repeated holding steps inflate cost, consume space, and block automation.

06

No process intensification

Without cost-effective perfusion, cell densities and output stay capped.

Tanda enables higher productivity at both ends.

One platform built for the small end, one for the large — each designed to lift what a process can actually produce.

Small Scale

Small-volume, simple, high-throughput filtration for research and process development — led by the TxFlow™ Go benchtop system and purpose-built ReadyPath™ flow consumables.

TxFlow Go with ReadyPath flow path consumables
Explore Small Scale →

Large Scale

Reusable perfusion systems and a novel channel filter design for large-scale biomanufacturing, industrial biotech and environmental applications — cutting cost and waste at scale.

Tanda reusable process filtration system
Explore Large Scale →

Four things worth knowing.

TxFlow Go benchtop filtration system
Small Scale

TxFlow™ Go

The go-to system for day-to-day lab-scale filtration — automated, reproducible, and ready in minutes, down to sub-mL volumes.

0.5 mL – 2 LProcessing range
Learn more →
ReadyPath pre-configured flow path
Small Scale

ReadyPath™ Flow Path

Pre-configured, purpose-built flow path consumables for the TxFlow™ Go — no assembly, minimal hold-up volume, and validated run-to-run reproducibility.

Ready to runPre-configured flow path
Learn more →
Coming soon
Large Scale

Perfusion Intensification

Cost-effective reusable perfusion filtration unlocks dramatically higher cell densities — boosting bioreactor output 5–10× through process intensification.

5–10×Bioreactor output
Learn more →
Tanda reusable process filtration system
Large Scale

Streamlined Downstream

A re-engineered flow-channel and modular design that cuts cleaning time and cost by 70% and triples effective processing capacity — reusable, with far less waste.

3× capacity70% lower cleaning cost
Learn more →

Ready to transform your bioprocess?

Talk to our team about the right Tanda platform for your scale.

Contact us →

Supported by leading innovation programs.

We appreciate the support of federal agencies, world-class universities, and Illinois state innovation programs.

NSF SBIR University of Chicago Polsky Center Illinois Innovation Voucher Illinois DCEO

Acknowledgment: This work is supported in part by NSF SBIR funding, the University of Chicago Polsky Center, the Illinois Innovation Voucher program, and the Illinois Department of Commerce & Economic Opportunity. Any opinions, findings, and conclusions expressed are those of the authors and do not necessarily reflect the views of these organizations.